TITLE

Safety and efficacy of Intacs in Indian eyes with keratoconus: An initial report

PUB. DATE
March 2009
SOURCE
Indian Journal of Ophthalmology;Mar2009, Vol. 57 Issue 2, p115
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
36659203

 

Related Articles

  • Safety and efficacy of Intacs in Indian eyes with keratoconus: An initial report. Parthasarathy, Anand // Indian Journal of Ophthalmology;Mar2011, Vol. 59 Issue 2, p173 

    A letter to the editor is presented in response to the article "Safety and efficacy of Intacs in Indian eyes with keratoconus: An initial report," by Dr. Rohit Shetty.

  • Author's reply. Shetty, Rohit // Indian Journal of Ophthalmology;Mar2011, Vol. 59 Issue 2, p173 

    A response by Dr. Rohit Shetty to a letter to the editor about his article "Safety and efficacy of Intacs in Indian eyes with keratoconus: An initial report," is presented.

  • Implanting intracorneal ring segments may delay penetrating keratoplasty. Nale, Pat // Ocular Surgery News Europe/Asia-Pacific Edition;Apr2009, Vol. 20 Issue 4, p18 

    The article focuses on a study which examined the use of Intacs implantation in 14 Asian-Indian eyes with advanced keratoconus.

  • Treating Keratoconus With Intacs Corneal Ring Segments. Hellstedt, Timo; Makela, Janna; Uusitalo, Raimo; Emre, Sinan; Uusitalo, Risto // Journal of Refractive Surgery;May2005, Vol. 21 Issue 3, p236 

    PURPOSE: To assess the safety and efficacy of Intacs inserts for the treatment of mild to moderate keratoconus. METHODS: In a nonrandomized prospective clinical trial, 50 eyes of 37 patients with mild to moderate keratoconus were implanted with asymmetrical pairs of Intacs segments. Patients...

  • Cornea. Shovlin, Joseph P. // Review of Optometry;5/15/2003, Vol. 140 Issue 5, p45 

    Determines the advancement of dry-eye management for corneal disorders. Efficacy of levofloxacin on the treatment of Serratia keratitis; Safety of moxifloxacin for treating bacterial conjunctivitis; Association of obesity with keratoconus. INSETS: Obesity as a Cause of Keratoconus?;Treating HSV.

  • Photorefractive keratectomy with corneal collagen cross-linking 1 year after intrastromal corneal ring segment implantation for the treatment of keratoconus. Elfayoumi, Maha; Abdelwahab, Shereef // Journal of Egyptian Ophthalmological Society;Jun2016, Vol. 10 Issue 2, p65 

    Purpose The aim of the present study was to report the improvement in unaided visual acuity in nonprogressive keratoconus cases previously treated with intrastromal corneal ring segment implants (Intacs) after topography-guided photorefractive keratectomy (PRK) and corneal collagen cross-linking...

  • FDA designates prescription inserts as 'corneal implants'.  // Ophthalmology Times;2/1/2006, Vol. 31 Issue 3, p57 

    The article reports that the firm Addition Technology Inc. has received approval from the United States Food and Drug Administration to use the term corneal implants to describe its prescription inserts known as Intacs. Intacs have been used to solve keratoconus and ectasia in corneal and...

  • Post intrastromal corneal ring segments insertion complicated by Candida parapsilosis keratitis. Mitchell, Bradley M.; Kanellopoulos, A. John; Font, Ramon L. // Clinical Ophthalmology;2013, Vol. 7, p443 

    This case report describes the clinical and histopathologic features, including molecular confirmation, of fungal keratitis after intrastromal corneal ring segments placement for keratoconus. A 52-year-old woman underwent insertion of Intacs® corneal implants for treatment of keratoconus....

  • Efficacy and Safety of Intacs SK in Moderate to Severe Keratoconus. El-Moatassem Kotb, Ahmed M.; Hantera, Mohamed // Middle East African Journal of Ophthalmology;Jan-Mar2013, Vol. 20 Issue 1, p46 

    Purpose: To examine the safety and efficacy of Intacs SK for moderate to severe keratoconus (KC) using femtosecond technology. Materials and Methods: This prospective, non-comparative study included 37 contact lens intolerant keratoconic eyes (stage II-III) of 24 patients who underwent...

  • Addition Technology launches CXL system.  // Optometry Times;Nov/Dec2011, Vol. 3 Issue 10, p5 

    The article reports on the launching of corneal collagen crosslinking (CXL) system (Intacs XL) by Addition Technology Inc. as treatment option for keratoconus and other opthalmic related conditions in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics